Mastering Medical
USMLE Step 1 · Pharmacology

Flumazenil vs Naloxone

How to tell Flumazenil and Naloxone apart when a board question makes them look alike.

Fastest separator

Flumazenil reverses benzodiazepine sedation but can cause seizures; naloxone reverses opioid respiratory depression.

Side by side

FlumazenilNaloxone
Key clue

Benzodiazepine-site antagonist for carefully selected isolated benzodiazepine sedation; seizure risk limits routine use.

Opioid receptor antagonist for respiratory depression with miosis or suspected opioid overdose.

Mechanism

Flumazenil competitively antagonizes the benzodiazepine binding site on GABA-A receptors.

Naloxone competitively antagonizes opioid receptors and reverses opioid-induced respiratory depression.

Labs and tests

Known isolated benzodiazepine exposure without chronic use or proconvulsant coingestion points possible flumazenil.

Coma plus hypoventilation and pinpoint pupils points naloxone.

The trap

Mixed-overdose patients with depressed consciousness should NOT receive flumazenil reflexively. Flumazenil precipitates withdrawal seizures in patients chronically dependent on benzodiazepines, and the seizure risk is far worse if the co-ingestion contains a proconvulsant such as a tricyclic antidepressant, cocaine, or bupropion. Naloxone reverses opioid respiratory depression with much lower risk. In an unknown overdose with respiratory depression, treat the life threat with naloxone first, then support airway and breathing; reserve flumazenil for pure isolated iatrogenic benzodiazepine sedation (procedural sedation reversal in a benzodiazepine-naive patient).

The repair move

In overdose stems, treat the life threat first: airway and opioid respiratory depression before a risky sedation reversal.

Try a free question

Core

A child accidentally receives a benzodiazepine during a procedure and has isolated oversedation. A benzodiazepine receptor antagonist is considered. Which drug is this?

Show answer and explanation

Answer: A. Flumazenil. Flumazenil antagonizes the benzodiazepine site on GABA-A receptors and can reverse benzodiazepine sedation in carefully selected cases.

Why the other choices are tempting

  • B. Naloxone reverses opioid toxicity with respiratory depression.
  • C. Naltrexone is a long-acting opioid antagonist for relapse prevention.
  • D. Pralidoxime reactivates acetylcholinesterase in organophosphate poisoning.
  • E. Physostigmine can reverse selected antimuscarinic toxicity but is not a benzodiazepine antagonist.

Flashcards

Tap a card to flip it.

What is the fastest separator for Flumazenil vs Naloxone?

Flumazenil reverses benzodiazepine sedation but can cause seizures; naloxone reverses opioid respiratory depression.

What clue should make you choose Flumazenil?

Benzodiazepine-site antagonist for carefully selected isolated benzodiazepine sedation; seizure risk limits routine use.

Quick answers

What is the fastest way to tell Flumazenil from Naloxone?

Flumazenil reverses benzodiazepine sedation but can cause seizures; naloxone reverses opioid respiratory depression.

What is the key clue for Flumazenil?

Benzodiazepine-site antagonist for carefully selected isolated benzodiazepine sedation; seizure risk limits routine use.

What is the key clue for Naloxone?

Opioid receptor antagonist for respiratory depression with miosis or suspected opioid overdose.

What is the common trap with Flumazenil vs Naloxone?

Mixed-overdose patients with depressed consciousness should NOT receive flumazenil reflexively. Flumazenil precipitates withdrawal seizures in patients chronically dependent on benzodiazepines, and the seizure risk is far worse if the co-ingestion contains a proconvulsant such as a tricyclic antidepressant, cocaine, or bupropion. Naloxone reverses opioid respiratory depression with much lower risk. In an unknown overdose with respiratory depression, treat the life threat with naloxone first, then support airway and breathing; reserve flumazenil for pure isolated iatrogenic benzodiazepine sedation (procedural sedation reversal in a benzodiazepine-naive patient).